Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 6784195
Pyrazole compositions useful as inhibitors of ERK
expired -
US 6784156
Cyclosporins for the treatment of respiratory diseases
expired -
US 6783760
Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
expired -
US 6783763
Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines
expired -
US 6783936
Antigenic epitopes with Lym-1 reactivity and uses thereof
expired -
US 6784314
Process for producing amine derivatives
expired -
US 6780847
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
expired -
US 6780984
Method for prognosing cancer and the proteins involved
expired -
US 6780969
Synthetic peptide composition as immunogens for prevention of urinary tract infection
expired -
US 6780890
Compounds and methods for regulating bacterial growth and pathogenesis
expired -
US 6780837
Prevention of retinal injury and degeneration by specific factors
expired -
US 6780640
Human carboxypeptidases and polynucleotides encoding the same
expired -
US 6780417
Transmission blocking immunogen from malaria
expired -
US 6780414
METHODS OF IDENTIFYING BACTERIAL GENES THAT ARE INCOMPATIBLE WITH BACTERIAL PATHOGENICITY, AND THE USE OF SUCH GENES, SUCH AS CADA, TO REDUCE PATHOGENICITY IN A BACTERIA OR TO COMBAT PATHOGENIC BACTERIAL INFECTIONS
expired -
US 6780586
Methods of diagnosing breast cancer
expired -
US 6780406
Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene
expired -
US 6780413
Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
expired -
US 6780995
Activated iododerivatives for the treatment of cancer and aids
expired -
US 6777231
Adipose-derived stem cells and lattices
expired -
US 6777200
Kinesin motor modulators derived from the marine sponge Adocia
expired -
US 6777389
Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
expired -
US 6777435
Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
expired -
US 6777578
Hydroxyphenstatin and the prodrugs thereof
expired -
US 6777179
Method for selective inactivation of viral replication
expired
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.